Koski Sari M, Laitinen-Parkkonen Pirjo, Airaksinen Marja
Division of Social Pharmacy, University of Helsinki, Helsinki, Finland.
Home and Institutional Care and Social Services, Hyvinkää, Finland.
Int J Health Plann Manage. 2015 Jul-Sep;30(3):260-75. doi: 10.1002/hpm.2233. Epub 2013 Dec 3.
The study aim was to explore the progress of legislation relating to herbal medicinal products in the European Union and compare it with the corresponding progress of the legislation in Finland in 1965-2007.
The study was carried out using content analysis. Data were searched from publicly available European Union directives and national acts. All definitions and safety-related requirements for herbal medicinal products were identified. The transposition of safety-related requirements into the national legislation was studied.
Medicinal products from plant origins have been part of the European Union legislation since 1965. Most plant-based products have not initially been regarded as medicinal products but rather as some kind of medicine-like products. The official definition of herbal medicinal products was introduced in Directive 2004/24/EC and implemented into the Finnish legislation with the terminology to recognise herbal medicinal products as part of medicinal products. The current safety-related requirements of medicinal products concern analogously herbal medicinal products.
Herbal medicinal products have had different definitions in pharmaceutical legislation over the study period in the European Union and Finland. The current definition places herbal medicinal products more clearly under the medicinal products' legislation. Safety-related requirements are now practically identical for all medicinal products. Transposition of the European Union legislation into the national legislation in Finland is apparent.
本研究旨在探讨欧盟草药产品相关立法的进展,并将其与芬兰1965 - 2007年相应的立法进展进行比较。
本研究采用内容分析法。数据从公开可得的欧盟指令和国家法案中检索。确定了草药产品的所有定义和与安全相关的要求。研究了将与安全相关的要求纳入国家立法的情况。
自1965年以来,植物源药品一直是欧盟立法的一部分。大多数植物基产品最初并未被视为药品,而是被视为某种类似药品的产品。草药产品的官方定义在2004/24/EC号指令中引入,并以将草药产品视为药品一部分的术语纳入芬兰立法。目前药品与安全相关的要求同样适用于草药产品。
在欧盟和芬兰的研究期间,草药产品在药品立法中有不同的定义。当前的定义将草药产品更明确地置于药品立法之下。现在所有药品与安全相关的要求实际上是相同的。欧盟立法在芬兰国家立法中的转化很明显。